Cargando…

Pentraxin 3 as a Novel Marker in Cardiovascular Diseases?

Pentraxin 3 (also known as TNFAIP5, TSG-14) belongs to the superfamily of proteins characterized by cyclic multimeric structure. Pentraxin 3 (PTX3) is synthesized locally at the inflammatory sites by endothelial and smooth muscle cells upon exposure to inflammatory signals such as IL-1β, TNF-α or ox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malinowski, Bartosz, Grzesk, Grzegorz, Grzesk, Elzbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975313/ https://www.ncbi.nlm.nih.gov/pubmed/27683398

Ejemplares similares

Potential Markers in Cardiac Hypertrophy?
por: Malinowski, Bartosz, et al.
Publicado: (2012)

Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism
por: Wiciński, Michał, et al.
Publicado: (2017)

PCSK9 signaling pathways and their potential importance in clinical practice
por: Wiciński, Michał, et al.
Publicado: (2017)

The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions
por: Szadujkis-Szadurska, Katarzyna, et al.
Publicado: (2016)

Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study
por: Grześk, Grzegorz, et al.
Publicado: (2021)

Extended List of Warning Signs in Qualification to Diagnosis and Treatment of Inborn Errors of Immunity in Children and Young Adults
por: Dąbrowska, Anna, et al.
Publicado: (2023)

Influence of celecoxib on the vasodilating properties of human mesenteric arteries constricted with endothelin-1
por: GRZEŚK, GRZEGORZ, et al.
Publicado: (2014)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023)

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference?
por: Chudzińska, Małgorzata, et al.
Publicado: (2022)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

Implementation of recommendations on the check of risk factors for cardiovascular diseases in patients undergoing coronary re-interventions
por: Walukiewicz, Marcin, et al.
Publicado: (2023)

Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
por: Inoue, Kenji, et al.
Publicado: (2012)

Current Modulation of Guanylate Cyclase Pathway Activity—Mechanism and Clinical Implications
por: Grześk, Grzegorz, et al.
Publicado: (2021)

Artificial Intelligence Technologies in Cardiology
por: Ledziński, Łukasz, et al.
Publicado: (2023)

The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target
por: Wołowiec, Anna, et al.
Publicado: (2023)

The Potential Role of RANTES in Post-Stroke Therapy
por: Pawluk, Hanna, et al.
Publicado: (2023)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up
por: Wołowiec, Łukasz, et al.
Publicado: (2020)

High-Dose, but Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells
por: Grześk, Grzegorz, et al.
Publicado: (2013)

Increased Oxidative Stress Markers in Acute Ischemic Stroke Patients Treated with Thrombolytics
por: Pawluk, Hanna, et al.
Publicado: (2022)

The inflammatory protein Pentraxin 3 in cardiovascular disease
por: Fornai, Francesco, et al.
Publicado: (2016)

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
por: Yoneda, Masato, et al.
Publicado: (2008)

Underexpanded stent in left anterior descending coronary artery treated with intravascular lithotripsy
por: Górny, Bartosz, et al.
Publicado: (2020)

Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke
por: Pawluk, Hanna, et al.
Publicado: (2022)

Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters
por: Nowaczyk, Alicja, et al.
Publicado: (2021)

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2013)

Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
por: Kołtan, Sylwia, et al.
Publicado: (2021)

Common variable immunodeficiency: different faces of the same disease
por: Grześk, Elżbieta, et al.
Publicado: (2021)

The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
por: Pawluk, Hanna, et al.
Publicado: (2020)

Pentraxins as Key Disease Markers for Periodontal Diagnosis
por: Kathariya, Rahul, et al.
Publicado: (2013)

The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications
por: Grześk, Grzegorz, et al.
Publicado: (2020)

Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children
por: Ye, Xiaolin, et al.
Publicado: (2021)

Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion
por: SZADUJKIS-SZADURSKA, KATARZYNA, et al.
Publicado: (2013)

Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
por: Shindo, Akihiro, et al.
Publicado: (2014)

Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis
por: Pawluk, Hanna, et al.
Publicado: (2020)

Pentraxin 3 as a marker of vasospasm following subarachnoid hemorrhage
por: Zanier, ER, et al.
Publicado: (2008)

Acetylsalicylic Acid–Primus Inter Pares in Pharmacology
por: Fijałkowski, Łukasz, et al.
Publicado: (2022)

Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge
por: Szczawińska-Popłonyk, Aleksandra, et al.
Publicado: (2021)

Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys
por: Ewertowska, Marlena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0mks5f5ku6f8rqfc2occrqk18m